The first cat I ever euthanized for feline infectious peritonitis was a seven-month-old orange tabby named Wendell. It was late in my residency, his owner had hand-raised him from a two-day-old bottle baby, and I remember sitting on the floor of the exam room with her because there was nothing left to say standing up. For most of my career, that’s what an FIP diagnosis meant: a quiet room, a broken heart, and a disease we had no answer for. Today, I write wellness certificates for cats who survived it. That shift — from a virtual death sentence to a genuinely curable disease — is one of the most remarkable stories in modern veterinary medicine, and it’s still unfolding.
A Disease With a Fifty-Year Head Start
Feline infectious peritonitis has been confounding veterinarians since it was first described as a distinct disease in the 1960s, and it wasn’t until the early 1980s that researchers connected it to coronavirus. Here’s the strange part: the virus behind FIP is remarkably common. Feline coronavirus circulates widely in cats, especially multi-cat households, shelters, and catteries, usually causing nothing worse than mild diarrhea. FIP happens when that ordinary virus mutates inside an individual cat — essentially, the virus changes its travel plans. Instead of staying in the gut, it hijacks the cat’s own immune cells and spreads throughout the body.
Only a small fraction of coronavirus-positive cats ever experience that mutation, but when it happens, the immune system’s panicked response does as much damage as the virus itself. The disease comes in a “wet” form, where fluid accumulates in the abdomen or chest, and a “dry” form without that fluid. Neurological and ocular versions are the most stubborn. And it disproportionately strikes young cats — most cases occur in kittens under two years old, which is exactly why rescues and shelters have always been hit so hard.
For decades, nothing worked. A vaccine introduced in 1991 offered, at best, incomplete protection and couldn’t help cats already exposed. Immunosuppressants bought weeks, not lives. Interferon, immune boosters, supplements — I watched desperate owners try all of it, and I understood the impulse completely. When the profession offers you nothing, you fill the vacuum however you can. As,[1] recounts, the field spent thirty years chasing dead ends.
The Ebola Drug on the Shelf
The breakthrough came from an unlikely direction. Dr. Niels Pedersen of UC Davis — who has spent his career on FIP — began screening experimental antiviral compounds from the pharmaceutical company Gilead Sciences around 2012. One of them, GS-5734, caught his eye. You probably know that compound by another name: remdesivir, the drug shelved after Ebola trials, later famous as a COVID-19 treatment.
Pedersen’s team zeroed in on its sister compound, GS-441524, which blocks the virus from copying its genetic material. The field trials published in 2018 and 2019 were stunning: roughly 96.7% of treated cats survived — cats that, by every historical expectation, should have died. I remember reading those results and feeling something I’d rarely felt about this disease: hope. I had spent years telling owners FIP was untreatable. I’ve had to unlearn that, and honestly, unlearning it felt wonderful.
When the Cure Was Technically Illegal
Then came the part of the story that still makes my jaw clench. Gilead held the patents on GS-441524 and declined to license it for veterinary use. The company never fully explained why — a small potential market and human drug pipeline priorities are the reasons usually cited — but the practical effect was that a proven cure for a uniformly fatal disease sat locked away while cats kept dying.
Owners did not accept that. An underground network sprang up, centered on the Facebook community FIP Warriors 5.0, connecting desperate owners with unregulated imported compounded drug — often from chemical suppliers in China, of unverifiable purity, at costs that typically ranged from $3,000 to well over $10,000 for a full course depending on the cat’s weight and treatment length. Early treatment meant painful daily injections under the skin, which cats tolerated about as well as you’d imagine, until oral formulations appeared and transformed the experience.
Veterinarians like me operated in an awkward gray zone. We legally couldn’t prescribe the drug, but many of us quietly monitored bloodwork and cheered from the sidelines. There were legitimate safety debates, too — group administrators with no veterinary credentials were making dosing recommendations, which played out uncomfortably in professional forums. But I’ll say what many of us thought privately: unregulated medicine saved thousands of cats that regulated medicine had abandoned.
The irony peaked in May 2020, when remdesivir received FDA authorization as a COVID-19 treatment in humans — while cat owners still couldn’t legally obtain essentially the same molecule for their dying cats.
Science Finally Catches Up
The landscape has shifted dramatically in the past few years. Compounding pharmacies in Australia and the UK began legally compounding remdesivir for cats around 2021–2022, creating the first legitimate access pathway. In 2024, the FDA opened a door for legally compounded remdesivir for FIP treatment in the United States — effectively ending the black-market-only era there.
The science has come out into the daylight, too. Colorado State University recently completed [2] and found the treatment roughly 77% effective. If you’ve seen UC Davis’s 96.7% figure, that lower number deserves context, not alarm. The controlled trials treated healthier, earlier-stage cats; the CSU work reflects real-world cases, including advanced neurological disease and cats who arrived already critically ill. In my clinical experience, the gap between those numbers is largely about how quickly treatment starts.
Rescue organizations have been among the biggest beneficiaries. One rescue group:[3]
“This is a miracle for shelter cats. Imagine a world where a disease that used to [be a death sentence] is now treatable.”
They weren’t exaggerating. That organization alone has cured 27 foster cats since 2020, with eight more currently in treatment. Think about what that means for shelter medicine: cats who would once have been euthanized on diagnosis are now adoptable.
What Treatment Actually Looks Like Today
Time is everything
FIP is a master mimic — it looks like a hundred other illnesses, and cats are frequently lost to diagnostic delay, not treatment failure. If your young cat has unexplained fever, weight loss, lethargy, a bloated abdomen, or wobbly hind-end movement that keeps recurring despite antibiotics, push for a workup. Early, aggressive treatment is the single strongest predictor of a good outcome.
The 84-day marathon
Standard protocol is a daily antiviral for a minimum of 84 days — twelve weeks — with longer courses for neurological or ocular disease, since the virus hides in those hard-to-reach tissues. Dosing is calculated by your veterinarian based on your cat’s weight and disease form, and it’s genuinely a conversation you need to have with a vet who’s current on FIP protocols, not something to improvise. Oral medication has made this marathon far more livable for both cats and the humans pilling them.
Watching the bloodwork
Cure isn’t declared on faith. We track globulin levels, white blood cell counts, and the albumin-to-globulin ratio over the course of treatment and afterward, because relapse typically shows up within weeks of stopping. Follow-up matters — a cat who finishes treatment isn’t done until the numbers agree.
I think of a kitten I’ll call Pickles, a twelve-week-old shelter stray I saw last year — wet FIP, caught early, treated legally with compounded medication, and now a fourteen-pound menace to a squeaky mouse toy. Six years ago, her chart would have ended with a euthanasia consent form. Her owner’s last note to me read, “She doesn’t know she was ever sick.” That’s the whole revolution in one sentence.
The takeaway, especially for rescue advocates: FIP is no longer a euthanasia diagnosis, and every shelter volunteer, foster, and cat owner should know it. If we’ve learned anything from this saga, it’s that informed, stubborn people — owners who refused to accept “nothing can be done” — dragged this cure into existence years before institutions caught up. Cats in shelters and catteries, where this disease does its worst damage, now have a fighting chance, and the calculus of rescue has permanently changed. Demand the treatment, support the rescues funding it, and never let anyone tell you FIP is a death sentence. It’s a disease we beat now — and the cats are living proof.
Sources
- veterinary journalist Steve Dale's detailed history of the disease — navta.net
- the largest clinical trial of antiviral therapy for naturally occurring FIP — source.colostate.edu
- described the shift plainly on social media — facebook.com